Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Rosuvastatin 20 mg vs Crestor 20 mg in Healthy Thai Volunteers (Fasting)
TCTR20200322001Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia and dyslipidemia (2 arms), sponsored by International Bio Service. Primary endpoint: Bioequivalence of rosuvastatin generic vs Crestor. Planned start May 2020; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on TCTR20200322001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200322001.